On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion

Statistics in Medicine

Volumn 19, Issue 13, 2000, Pages 1753-1769

  Geskus, Ronald B ^a,b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DATA ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; PROBABILITY; SEROCONVERSION; SEROPREVALENCE; STATISTICAL ANALYSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HOMOSEXUALITY, MALE; HUMANS; MALE; NETHERLANDS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 0034662079     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0258(20000715)19:13<1753::AID-SIM487>3.0.CO;2-F     Document Type: Article

References (16)

1. Brookmeyer R, Gail MH. AIDS Epidemiology, a Quantitative Approach. Oxford University Press: 1994.
2. Longini IM, Clark WS, Byers RH, Ward JW, Darrow WW, Lemp GF, Hethcote HW. Statistical analysis of the stages of HIV infection using a markov model. Statistics in Medicine 1989; 8:831-843.
3. Hendriks JCM, Satten GA, Longini IM, van Druten HAM, Schellekens PTA, Coutinho RA, van Griensven GJP. Use of immunological markers and continuous-time markov models to estimate progression of HIV infection in homosexual men. AIDS 1996; 10:649-656.
4. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 1987; 36:1S-15S.
5. Robertson T, Wright FT, Dykstra RL. Order Restricted Statistical Inference. Wiley: New York, 1988.
6. Coutinho RA, Lelie PN, van Lent PA, Reerink-Brongers EE, Stoutjesdijk L, Dees P, Nivard J, Huisman J, Reesink HW. Efficacy of heat inactivated hepatitis b vaccine in male homosexuals: outcome of a placebo controlled double blind trial. British Medical Journal 1983; 286:1305-1308.
7. Gasser T, Müller HG. Kernel estimation of regression functions. In Smoothing Techniques for Curve Estimation, Vol. 757 of Lecture Notes in Mathematics. Springer-Verlag: 1979; 23-68.
8. Prummel MF, ten Berge RJM, Barrowclough H, Cejka V. Kaposi sarcoom en dodelijke opportunistische infecties bij een homoseksuele man met een deficient immuunapparaat. Nederlands Tijdschrift Voor Geneeskunde 1983; 127: 820-824.
9. Veugelers PJ, van Zessen G, Hendriks JCM, Sandfort TGM, Coutinho RA, van Griensven GJP. Estimation of the magnitude of the HIV epidemic among homosexual men: utilization of survey data in predictive models. European Journal of Epidemiology 1993; 9:436-441.
10. Davison AC, Hinkley DV. Bootstrap Methods and Their Applications. Cambridge University Press: 1997.
11. Politis DN, Romano JP. Large sample confidence regions based on subsamples under minimal conditions. Annals of Statistics 1994; 22:2031-2050.
12. Harrell FE. Design: S functions for biostatistical/epidemiologic modeling, testing, estimation, validation, graphics, and prediction. 1998, programs available from http://hesueb1.med.virginia.edu /biostat/s/index.htm1 or from http://1ib.stat.cmu.edu /(DOS/)/S.
13. Veugelers PJ, Strathdee SA, Kaldor JM, Shafer KA, Moss AR, Schlechter MT, Schellekens PTA, Coutinho RA, van Griensven GJP. Associations of age, immunosuppression and AIDS among homosexual men in the tricintinental seroconverter study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997; 14:435-441.
14. Muñoz A, Wang M-C, Bass S, Taylor JMG, Chmiel JS, Kingsley L, Polk BF. The Multicenter AIDS Cohort Study Group. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. American Journal of Epidemiology 1989; 130:530-539.
15. Muñoz A, Carey V, Taylor JMG, Chmiel JS, Kingsley L, van Raden M, Hoover DR. Estimation of time since exposure for a prevalent cohort. Statistics in Medicine 1992; 11:939-952.
16. Alcabes P, Muñoz A, Vlahov D, Friedland GH. Incubation period of human immunodeficiency virus. Epidemiologic Reviews 1993; 15:303-318.